ECO Animal Health Group (LON:EAH) Given Buy Rating at Shore Capital

Shore Capital restated their buy rating on shares of ECO Animal Health Group (LON:EAH - Free Report) in a report published on Wednesday morning, MarketBeat reports.

ECO Animal Health Group Trading Up 6.7 %

LON EAH traded up GBX 7.50 ($0.09) during mid-day trading on Wednesday, hitting GBX 120 ($1.51). The company's stock had a trading volume of 115,803 shares, compared to its average volume of 141,106. The company has a debt-to-equity ratio of 4.57, a current ratio of 3.16 and a quick ratio of 2.14. The firm has a market capitalization of £81.29 million, a P/E ratio of -6,000.00 and a beta of 0.07. The stock's fifty day simple moving average is GBX 94.24 and its two-hundred day simple moving average is GBX 102.62. ECO Animal Health Group has a 52-week low of GBX 82.67 ($1.04) and a 52-week high of GBX 124 ($1.56).

ECO Animal Health Group Company Profile

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.